Press releases
- Emerson Releases 2023 Sustainability Report
- Emerson Announces Sale of Remaining Interests in Copeland to Blackstone
- Calvin Butler to Join Emerson's Board of Directors
- Emerson Reports Second Quarter 2024 Results; Updates 2024 Outlook
- NI Connect Spotlights Pivotal Role of Test to Drive Innovation and Performance Gains
- Emerson Schedules Second Quarter 2024 Earnings Release and Conference Call
- Emerson's Next-Generation Software Streamlines Pharmaceutical Development, Accelerates Speed to Market
More ▼
Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 67.00 |
Low | 67.00 |
Bid | -- |
Offer | -- |
Previous close | 67.00 |
Average volume | -- |
---|---|
Shares outstanding | 572.10m |
Free float | 570.12m |
P/E (TTM) | 32.78 |
Market cap | 63.02bn USD |
EPS (TTM) | 3.36 USD |
Annual div (ADY) | 1.90 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | May 16 2024 |
Div pay-date | Jun 10 2024 |
Data delayed at least 15 minutes, as of Mar 26 2019 13:42 BST.
More ▼